CoChat

Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: Results from a randomized controlled trial

Sikjaer, T., Rolighed, L., Hess, A., Fuglsang-Frederiksen, A., Mosekilde, L., Rejnmark, L. · 2014 · Osteoporosis International

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Unlabelled The effects of treatment with 100 μg parathyroid hormone (PTH) (1-84) or an identical placebo on muscle function and quality of life (QoL) was studied in hypoparathyroid patients. At baseline, we found reduced QoL but no myopathy in the patients. Six months of treatment did not improve QoL, and muscle strength decreased slightly.Introduction A reduced quality of life (QoL) and myopathy that may be due to the absence of PTH have been reported in patients with hypoparathyroidism (hypoPT).Methods Sixty-two patients with chronic hypoPT were randomized to 6 months of treatment with either PTH(1-84) 100 μg/d s.c. or placebo, given as add-on therapy to conventional treatment. Muscle function and postural stability were investigated using a dynamometer chair, a stadiometer platform, the repeated chair stands test, the timed up and go test, and electromyography. QoL was assessed using the 36-item Short Form Health Survey and the WHO-5 Well-Being Index.Results The mean age of the patients was 52 ± 11 years, and 85 % were females. At baseline, QoL was significantly reduced in comparison with norm-based scores. Compared with placebo, PTH did not improve QoL or muscle function. Rather, max force production decreased significantly by 30 % at elbow flexion in the PTH group compared with the placebo group. Moreover, there was a nonsignificant trend for muscle strength to decrease in the upper extremities and on knee extension in response to PTH. Treatment did not affect postural stability. Electromyography showed a slight decrease in the duration of motor unit potentials in the PTH group, indicating a tendency toward myopathy, which, however was not symptomatic.Conclusions Overall, our data do not support an immediate beneficial effect of PTH replacement therapy on muscle function or QoL. A high frequency of hypercalcemia among our patients may have compromised the potential beneficial effects of reversing the state of PTH insufficiency.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00198-014-2677-6

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Van Offel JF, De Gendt CM, De Clerck LS, Stevens WJ (2000) High bone mass and hypocalcaemic myopathy in a patient with idiopathic hypoparathyroidism. Clin Rheumatol 19:64–66

Cited by

See all 136

Metadata

Authors
Sikjaer, T., Rolighed, L., Hess, A., Fuglsang-Frederiksen, A., Mosekilde, L., & Rejnmark, L.
Affiliations
Aarhus University Hospital (DK)
Venue
Osteoporosis International
Published
2014-04-01
Volume
25
Issue
6
Pages
1717-1726
ISSN
  • 0937-941X (ISSN-L)
  • 1433-2965
OpenAlex
W2091222735
Cited by
134
References
44
Citations by year
2026: 5 · 2025: 9 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 14 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 12 · 2016: 7 · 2015: 11 · 2014: 4
FWCI
8.96
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Osteoporosis International (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
parathyroid hormone 1-84, hypoparathyroidism, parathyroid hormone replacement therapy, muscle function, muscle strength, quality of life, myopathy, postural stability, hypercalcemia, electromyography, motor unit action potentials
MeSH terms
Adult, Aged, Body Composition, Double-Blind Method, Electromyography, Postural Balance, Female, Humans, Hypoparathyroidism, Male, Middle Aged, Parathyroid Hormone, Psychometrics, Quality of Life, Treatment Outcome, Muscle, Skeletal, Hormone Replacement Therapy, Muscle Strength

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: Results from a randomized controlled trial. https://app.cochat.ai/papers/10.1007/s00198-014-2677-6
The paper
Sikjaer, T., Rolighed, L., Hess, A., Fuglsang-Frederiksen, A., Mosekilde, L., & Rejnmark, L. (2014). Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: Results from a randomized controlled trial. Osteoporosis International. https://doi.org/10.1007/s00198-014-2677-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.